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INTRODUCTION
Despite having multiple non-surgical options for the treat-
ment of benign uterine disease, hysterectomy continues to be 
the second most commonly performed surgery in the United 
States [1]. A laparoscopic approach to hysterectomy, which 
has several benefits over the traditional abdominal technique 
[2], has had a modest adoption in the United States with only 
12% of hysterectomies performed laparoscopically in 2003 
[3]. Factors that might explain this slow adoption include the 
learning curve associated with the procedures, lack of suffi-
cient resident and fellow training, uneven availability of prop-
er equipment, and a low level of physician reimbursement [4]. 
Advances in robotic technology allowed the development 
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Objective: To compare the outcomes of total laparoscopic to robotic approach for hysterectomy and all indicated procedures 
after controlling for surgeon and other confounding factors.
Methods: Retrospective chart review of all consecutive cases of total laparoscopic and da Vinci robotic hysterectomies between 
August 2007 and July 2009 by two gynecologic oncology surgeons. Our primary outcome measure was operative procedure 
time. Secondary measures included complications, conversion to laparotomy, estimated blood loss and length of hospital stay. 
A mixed model with a random intercept was applied to control for surgeon and other confounders. Wilcoxon rank-sum, chi-
square and Fisher’s exact tests were used for the statistical analysis.
Results: The 124 patients included in the study consisted of 77 total laparoscopic hysterectomies and 47 robotic hysterectomies. 
Both groups had similar baseline characteristics, indications for surgery and additional procedures performed. The difference 
between the mean operative procedure time for the total laparoscopic hysterectomy group (111.4 minutes) and the robotic 
hysterectomy group (150.8 minutes) was statistically significant (p=0.0001) despite the fact that the specimens obtained in the 
total laparoscopic hysterectomy group were significantly larger (125 g vs. 94 g, p=0.002). The robotic hysterectomy group had 
statistically less estimated blood loss than the total laparoscopic hysterectomy group (131.5 mL vs. 207.7 mL, p=0.0105) however 
no patients required a blood transfusion in either group. Both groups had a comparable rate of conversion to laparotomy, 
intraoperative complications, and length of hospital stay.
Conclusion: Total laparoscopic hysterectomy can be performed safely and in less operative time compared to robotic 
hysterectomy when performed by trained surgeons.
Keywords: Total laparoscopic hysterectomy, da Vinci robot, Robotic hysterectomy
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of the da Vinci robotic system (Intuitive Surgical, Sunnyvale, 
CA, USA) for surgical procedures which gained United States 
FDA approval for hysterectomy in 2005. This system offers 
the features of a high resolution three-dimensional (3D) view 
and a wrist-like motion of the robotic arm, which provides 
finer and more dexterous movements [5]. Currently the da 
Vinci robotic hysterectomy is being increasingly utilized in the 
United States for benign and malignant indications [6]. How-
ever, important limitations of robotic surgery exist including 
the added operative time and cost associated with the robotic 
procedure. The most current da Vinci surgical system, da Vinci 
S, currently costs over $2 million US dollars and the additional 
direct cost per case has been estimated to range from $950 to 
$1,400 US dollars, which include the per case amortized use-
cost of the robotic system as well as the increased operating 
room and nursing time utilized specifically for robot set-up 
and docking [7]. Further, we estimate $1,000 to $1,500 US dol-
lars in disposable instruments used per case.
Currently, there are limited data that compares outcomes 
of total laparoscopic to a robotic approach to hysterectomy 
for the treatment of benign and malignant gynecologic pa-
thology and the studies often fail to control for surgeon and 
other possible confounding factors. The aim of our study is to 
determine and quantify if performing a robotic hysterectomy 
has actual benefits when compared to total laparoscopic hys-
terectomy when performed by surgeons with laparoscopic 
hysterectomy experience after controlling for relevant con-
founding factors. 
MATERIALS AND METHODS
We conducted a retrospective review of 124 women who 
underwent a total laparoscopic or robotic hysterectomy at 
two community hospitals in the New York area from August 
2007 to July 2009.  All surgeries were performed by one of two 
board certified gynecologic oncologists from Mount Sinai School 
of Medicine.  The procedures included in the study were total 
laparoscopic and robotic hysterectomy for benign and ma-
lignant indications performed at White Plains Hospital and 
Greenwich Hospital. Both surgeons that participated in the 
study are robotic surgery instructors/proctors and each had 
performed approximately 40 robotic hysterectomies prior to the 
study period. Institutional Review Board approval was obtained. 
1. Technique
The total laparoscopic hysterectomies were performed in the 
manner described below, most commonly using the Harmon-
ic Scalpel (Ethicon Endo-Surgery Inc., Cincinnati, OH, USA). 
The abdominal cavity was accessed through the umbilicus by 
the open technique as described by Hasson [8], and a balloon 
trocar was utilized in this 10 mm incision site. Three accessory 
5 mm trocars are used and placed in the right lower quadrant 
of the abdomen, left lower quadrant and suprapubic position. 
The hysterectomy technique begins with Harmonic access to 
the pararectal spaces by incising parietal peritoneum lateral 
to the infundibulopelvic (IP) ligaments. Ureters are identified 
on each side followed by ligation of the IP ligaments. Round 
ligaments are divided near the pelvic sidewall and the blad-
der dissected away in the usual manner. The uterine pedicles 
isolated and divided at the isthmus and carried down the 
paracervix to the level of the vaginal cuff. A colpotomy is 
created and extended with the laparoscopic scissors or the 
Harmonic Scalpel. The intact uterus was removed vaginally in 
patients with carcinoma except for three cases in which the 
intact uterus was removed abdominally through the umbilical 
port site (2 total laparoscopic hysterectomy cases with uterine 
weight of 349 g and 425 g and a robotic hysterectomy case 
with uterine weight of 304 g). Bilateral salpingoophorectomy, 
tumor debulking and pelvic and paraaortic lymph node dis-
section was performed in both total laparoscopic and robotic 
hysterectomy cases for malignant pathology as indicated 
(Table 1). 
In hysterectomies for benign pathology and an enlarged 
uterus, an automatic morcellator was used (Gynecare Morcel-
lex, Ethicon Endo-Surgery Inc.). The colpotomy site was closed 
with interrupted laparoscopic endo-knot sutures in the cases 
of total laparoscopic hysterectomy and with a continuous vic-
ryl running suture in the robotic hysterectomies. 
The robotic hysterectomies were performed with the da 
Vinci robot following the same general principals of the total 
laparoscopic hysterectomy except for the use of monopolar 
and bipolar energy, and closure of the vaginal colpotomy, 
which was approximated in a running fashion. A cystoscopy 
was performed in selected cases of total laparoscopic and ro-
botic hysterectomy in which the surgeon deemed necessary 
to rule out a lower urinary tract injury (e.g., significant bladder 
dissection).
2. Data analysis
A computerized database was created to record the demo-
graphic information, body mass index (BMI), indication for 
hysterectomy, surgery performed, intraoperative findings, 
intraoperative complications, estimated blood loss (EBL, mL), 
conversion to laparotomy, use of morselator, other completed 
procedures, median specimen weight (g), mean lymph node 
dissection yield, operative procedure time (minutes), and total 
operating room time (minutes). Our primary outcome mea-Total laparoscopic hysterectomy vs. da Vinci robotic hysterectomy
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Table 1. Baseline characteristics and differences between the total laparoscopic hysterectomy and robotic hysterectomy groups for all surgical 
cases
Total laparoscopic hysterectomy,
(n=77)
Robotic hysterectomy,
(n=47) p-value*
Age (yr) 58.9±12.59 58.9±11.79 0.889
Body mass index (kg/m
2) 28.74±6.77 29.52±7.33 0.681
Median uterine weight (range) (g)  125 (35-1,740) 94 (29-515) 0.002
Operative procedure time (min) 111.45±33.22 150.82±33.50 <0.0001
Lymph node dissection yield
† 9.54±4.89 (n=37) 9.13±6.96 (n=23) 0.474
Indication 0.517
Benign 34 (44.15) 21 (44.68)
Malignant (endometrial carcinoma) 39 (50.64) 23 (48.93)
Cervical carcinoma in situ 2 (2.59) 3 (6.38)
Ovarian mass of unknown etiology 2 (2.59) 0
Estimated blood loss (mL) 0.009
<200   34 (47.88) 32 (72.72)
>200   37 (52.11) 12 (27.27)
Conversions to laparotomy
Yes 3 (3.89) 0 0.288
No 74 (96.10) 47 (100)
Intraoperative complications
Yes 1 (1.29) 0 1.000
No 76 (98.70) 47 (100)
Lysis of adhesions
Yes 11 (14.28) 6 (12.76) 0.811
No 66 (85.71) 41 (87.23)
Salpingoophorectomy
Yes 72 (93.50) 44 (93.61) 1.000
No 5 (6.49) 3 (6.38)
Cystoscopy
Yes  7 (9.09) 6 (12.76) 0.517
No 70 (90.90) 41 (87.23)
Tumor debulking
Yes 2 (2.59) 0 0.525
No 75 (97.40) 47 (100)
Use of morcellator
Yes  6 (7.79) 1 (2.12) 0.251
No 71 (92.20) 46 (97.87)
Appendectomy
Yes 2 (2.59) 1 (2.12) 1.000
No 75 (97.40) 46 (97.87)
Length of hospital stay (day) 2.2±1.14 1.9±0.95  0.100
Both surgeons that participated in the study are robotic surgery instructors/proctors and each had performed approximately 40 robotic 
hysterectomies prior to the study period. Values are presented as mean±SD or number (%). 
*p-values were obtained by Wilcoxon rank-sum tests for continuous variables and by chi-square or Fisher’s exact tests for categorical variables. 
†For malignant cases.Enrique Soto, et al.
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sure was mean operative procedure time, which was defined 
as time from skin incision to skin closure.
The associations of patient characteristics and clinical vari-
ables of the total laparoscopic and robotic hysterectomy 
groups were assessed using Wilcoxon rank-sum tests for 
continuous variables and chi-square or Fisher’s exact tests for 
categorical variables. Data on operative procedure time were 
transformed with square root to remove skewness in the data. 
Mixed model with a random intercept to account for correla-
tion among patients who received surgeries from the same 
surgeon was used to examine effects of total laparoscopic 
and robotic hysterectomy on mean operative procedure time 
adjusted for other confounders. Variables examined included 
age, BMI, uterine weight, estimated blood loss, conversion to 
laparotomy, intraoperative complications, surgery date, lysis of 
adhesions, salpingoophorectomy and additional procedures 
performed including cystoscopy, tumor debulking, use of 
morselator, and appendectomy.  
All statistical analyses were performed using SAS ver. 9.2 (SAS 
Inc., Cary, NC, USA) and SPSS ver. 17.0 (SPSS Inc., Chicago, IL, 
USA). All p-values were two-tailed, with p < 0.05 considered as 
statistically significant results.
RESULTS
Between August 2007 and July 2009 there were a total of 124 
consecutive total laparoscopic and robotic hysterectomies in 
both institutions. These included 77 total laparoscopic hyster-
ectomies and 47 robotic hysterectomies for benign or malig-
nant indications and were performed by one of two surgeons. 
The patients in both groups had a comparable mean age 
(total laparoscopic hysterectomy, 58.9; robotic hysterectomy, 
58.9; p=0.889), indications for surgery and body mass index 
(total laparoscopic hysterectomy, 28.7 vs. robotic hysterec-
tomy, 29.5; p=0.681). The difference in incidence of both con-
version to laparotomy and intraoperative complications was 
not statistically significant in both groups (Table 1). The speci-
mens obtained in the total laparoscopic hysterectomy group 
were significantly larger than the specimens obtained in the 
robotic hysterectomy group (125 g vs. 94 g, p=0.002).
There were sixty-two patients that had hysterectomy for a 
malignant etiology (39 in the total laparoscopic hysterectomy 
group and 23 in the robotic hysterectomy group). All patients 
had endometrial carcinoma for which they underwent a total 
hysterectomy, bilateral salpingoophorectomy and pelvic/
paraaortic lymph node dissection (except for two patients 
that declined lymph node dissection in the total laparoscopic 
group). There were two patients in the total laparoscopic 
hysterectomy group that required tumor debulking as part 
of the staging procedure. The total laparoscopic and robotic 
hysterectomy groups had comparable lymph node yield (total 
laparoscopic hysterectomy, 9.54 vs. robotic hysterectomy, 9.13; 
p=0.474) (Table 2). 
The total laparoscopic hysterectomy group had significantly 
more patients with EBL greater than 200 mL in comparison to 
Table 2. Differences between the total laparoscopic hysterectomy and robotic hysterectomy groups for malignant indication (endometrial carcinoma)
Total laparoscopic hysterectomy,
(n=39)
Robotic hysterectomy,
(n=23)
p-value*
Age (yr) 62.69±11.91 63.92±11.21 0.687
Body mass index (kg/m
2) 31.07±7.10 29.94±5.88 0.518
Median uterine weight (g) 116.72±72.29 101.50±96.05 0.476
Operative procedure time (mins) 116.08±25.06 171.17±43.18 <0.001
Lymph node dissection 37 (94.87)
† 23 (100) 0.525
Lymph node dissection yield 9.54±4.89 9.13±6.96  0.474
Tumor debulking 2 (5.12) 0 0.525
Conversion to laparotomy 0 0 1.000
Intraoperative complications 0 0 1.000
Endometrial carcinoma stage
I 29 (74.35) 19 (82.60) 0.541
II 2 (5.12) 1 (4.34) 1.000
III 8 (20.51) 3 (13.04) 0.516
Values are presented as mean±SD or number (%).
*p-values were obtained by Wilcoxon rank-sum tests for continuous variables and by chi-square or Fisher’s exact tests for categorical variables. 
†Two patients declined lymph node dissection at the time of surgical consent.Total laparoscopic hysterectomy vs. da Vinci robotic hysterectomy
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the robotic hysterectomy group; this difference was statisti-
cally significant (37 vs. 12, p=0.009). The estimated blood loss 
in the total laparoscopic hysterectomy group was 207.7 mL 
and 131.50 mL in the robotic hysterectomy group; this differ-
ence was statistically significant (p=0.0105). The intraoperative 
complication encountered in the total laparoscopic hyster-
ectomy group (1.29%) consisted of a cystotomy that was re-
paired laparoscopically. Both groups had comparable hospital 
length of stay. The length of stay was 2.2 days in the total 
laparoscopic hysterectomy group and 1.9 days in the robotic 
hysterectomy group (p=0.10).
Total laparoscopic hysterectomies were performed an aver-
age 39 minutes faster than robotic hysterectomies. The differ-
ence between the mean operative procedure time for the to-
tal laparoscopic hysterectomy group (111.4 minutes) and the 
robotic hysterectomy group (150.8 minutes) was statistically 
significant (p=0.0001). The factors that were associated with 
a significant increase in operative procedure time were type 
of hysterectomy -robotic hysterectomy- (p=0.0001), surgeries 
where there was a greater than 200 mL blood loss (p=0.0002) 
and use of a morselator (p=0.007). Cystoscopy was associated 
with an increased operative procedure time but did not reach 
statistical significance (Table 3).
DISCUSSION
The current study compares the outcomes of total laparo-
scopic to robotic approach for hysterectomy and all indicated 
procedures after controlling for surgeon and other possible 
confounding factors. In our study, total laparoscopic hysterec-
tomies were performed for benign or malignant indications 
an average 39 minutes faster than robotic hysterectomies. 
Exclusion of the subset of patients that had multiple proce-
dures and/or conversion to laparotomy did not affect these 
results. The finding of reduced operative time associated with 
total laparoscopic hysterectomy is consistent with the major-
ity of the studies in the literature that compare this type of 
hysterectomy with a robotic approach. In the study by Payne 
and Dauterive [9], 2008, the robotic cases took an average 27 
minutes longer to complete. The authors state however that 
the last 25 robotic cases (of 100) were done faster than the 
average total laparoscopic hysterectomy (92.4 minutes vs. 
78.7 minutes). Other studies that had longer operative times 
for the robotic cohort, include the studies from Shashoua et 
al. [10], 2009 and Nezhat et al. [11], 2009 where there was an 
increased operative time of 20, and 70 minutes respectively.
The available studies in the literature that analyze specifically 
the use of a robotic versus a laparoscopic approach for surgi-
cal staging of endometrial carcinoma have shown conflicting 
results in regards to operative time. The studies by Seamon et 
al. [12], 2009 and Boggess et al. [13], 2008, found that the ro-
botic cohort had less operative time than the laparoscopic by 
approximately 45 minutes, and 22 minutes respectively. Other 
studies by Jung et al. [14], 2009 and Bell et al. [15], 2008 found 
that the laparoscopic cohort was an average 27 minutes, and 
13 minutes faster than the robotic cohort respectively. In the 
study by Bartos et al. [16], 2007, the implementation of the 
robot to their gynecologic oncology cases increased the over-
all cost and operative time by 59% in comparison to identical 
laparoscopic procedures in the same institution. 
Variability in the skill of the surgeon likely accounts for some 
of the inconsistencies seen in the literature. However, it is also 
possible that hospital dependent factors like anesthesia time, 
operating room staff efficiency and level of training of assis-
tants may play a role in these conflicting results. 
Our study confirmed the finding that the estimated blood 
loss is lower in robotic hysterectomies in comparison to total 
laparoscopic hysterectomies. Other authors that found similar 
results include Payne and  Dauterive [9], 2008, where there 
was a 52 mL difference favoring robotic hysterectomies. Stud-
ies that further prove this difference by having fewer blood 
transfusions in the total laparoscopic hysterectomy group 
include the studies from Boggess et al. [13], 2008, Jung et al. 
[14], 2009, and Bell et al. [15], 2008. In our study, the 76 mL 
blood loss difference in the groups had no evident clinical 
significance given that none of our patients required a blood 
transfusion and there were no complications directly related 
Table 3. Factors associated with operative procedure time
Least squares 
(means±SE)
Least squares 
(means in 
minutes)*
p-value
Total laparoscopic
  hysterectomy
13.33±0.33 177.7 <0.0001
Robotic hysterectomy 11.27±0.36 127.0
Estimated blood loss (mL)
<200 11.78±0.35 138.8 0.0002
>200 12.82±0.32 164.4
Use of morcellator
Yes  13.01±0.53 169.3 0.007
No 11.58±0.21 134.1
Cystoscopy
Yes  12.69±0.45 161.0 0.068
No 11.91±0.28 141.8
*Least squares means in minutes were obtained by transforming 
least squares means of the square root transformed data in column 2 
back to the original scale.Enrique Soto, et al.
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to blood loss. The etiology behind the difference in blood loss 
between these two techniques is yet to be determined. 
The data for complications for total laparoscopic vs. robotic 
hysterectomies have shown conflicting results. The study from 
Bell et al. [15], 2008 showed a lower complication rate for the 
robotic in comparison to the laparoscopic group (7.5% vs. 20.0%), 
while our study shared findings with Nezhat et al. [11], 2009 
showing no statistically significant difference in both groups. 
The complication we encountered (cystotomy) was repaired 
laparoscopically.  
With respect to rate of conversion to laparotomy, our study 
had similar results to Boggess et al. [13], 2008, by finding no 
statistically significant difference between the total lapa-
roscopic and robotic hysterectomy groups. The studies by 
Payne and Dauterive [9], 2008 and Seamon et al. [12], 2009 
however, showed a decrease in the rate of conversion to 
laparotomy in the robotic hysterectomy group in comparison 
to the total laparoscopic approach (4% vs. 9%, and 12% vs. 
26%, respectively). Additionally, there are two studies in the 
literature in which no conversions were reported (Nezhat et al. 
[11], 2009 and Jung et al. [14], 2009). Of note, the latter study 
was for staging of endometrial carcinoma and 83% of patients 
were stage I. Similarly, we included patients with endome-
trial carcinoma and our institutional practice is to perform a 
laparoscopic assessment for the cases with suspicion or with 
a known malignancy in order to determine resectability. This 
is performed whenever felt reasonable preoperatively with 
the purpose of avoiding unnecessary laparotomy in the cases 
where the intended outcome can be achieved laparoscopi-
cally. There is a definite need for larger studies to assess the 
expanding role of laparoscopy in gynecologic oncology. 
Typical indications for robotic hysterectomy include patient 
and/or physician preference. Patient preference may be driv-
en by patient-to-patient or by corporate direct-to-consumer 
marketing channels. Physician preference is based on the 
physician’s training and experience with each modality in-
cluding traditional laparoscopic, open, and robotic methods. 
The features of 3D visualization, play a role not only in visual 
field acquity/resolution, but also in camera control and image 
stability. Regarding the matter of the surgical assistance and 
console management, it is important to underline the para-
dox that exists. Many surgeons state that the console provides 
increasing personal control of the surgery and therefore a 
decreased dependence on the assistant. However at the same 
time, the presence of the primary surgeon remote and un-
scrubbed from the primary operative site results in a greater 
dependence on the ability of the assistant to complete the 
necessary ancillary functions in a timely and efficient manner.
Our study demonstrates that a traditional laparoscopic 
hysterectomy can be performed in less time than a robotic 
hysterectomy, while achieving similar outcomes. Therefore 
we raise the question: Would the generalized use of the robot 
be justified for this procedure? Our data does not support this 
claim. Robotic surgery is however a brilliant technology which 
may aid some physicians in the transition to a more minimally 
invasive approach to gynecologic surgery. 
Learning and incorporation of the robotic technique is 
certainly appropriate as all surgeons should be familiar with 
the full spectrum of available methods for treating patients. 
However, physicians should not relinquish their hard learned 
and mastered traditional laparoscopic techniques. Physicians 
should also be conscious of the costs. Our data demonstrate 
that for skilled laparoscopic surgeons, the robot rarely im-
proves the outcome as compared to a total laparoscopic ap-
proach to hysterectomy. 
The findings in our study suggest that total laparoscopic is 
an approach for hysterectomy that can be performed safely 
and in less operative time than using the robot when per-
formed by trained surgeons at institutions that have the prop-
er operative team and equipment. The decrease in operative 
time and lack of the costs associated with robotic surgery 
make total laparoscopic hysterectomy a likely better and more 
cost-effective approach to patients that require a hysterec-
tomy for a benign or malignant indication.
Our study has the limitations associated with a retrospective 
study and the results derive from a single institution with two af-
filiated hospitals. Prospective multicenter randomized studies 
are needed to definitively delineate the role of robotic surgery 
in the field of operative gynecology. Ideally, each surgeon should 
be familiar with both the total laparoscopic and robotic tech-
niques for hysterectomy and perform the procedure for which 
the surgeon has the most experience. The current data for ro-
botic hysterectomies does not demonstrate any clear benefits 
over traditional laparoscopy. Instead, robotic technology adds 
time and cost to the procedure. We believe that whenever a 
case can be done without the robot, it should be.
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